-
A Medical Milestone: FDA Approves First-Ever Treatment for Warm Autoimmune Hemolytic Anemia
NYSE: $JNJ A Breakthrough for Patients In a significant milestone for hematology and immunology, the FDA has officially approved Imaavy (nipocalimab-aahu). This approval marks a historical turning point as it is the first-ever treatment specifically indicated for adults with warm autoimmune hemolytic anemia (wAIHA). Understanding Warm Autoimmune Hemolytic Anemia (wAIHA) Warm autoimmune hemolytic anemia is…
-
A Major Milestone in Psoriatic Arthritis: FDA Approves Tremfya for Joint Damage Prevention
NYSE: $JNJ A Breakthrough for Psoriatic Arthritis Patients For those living with Psoriatic Arthritis (PsA), the goal of treatment has long been to manage pain and inflammation. However, a significant development from the FDA has raised the bar for what patients can expect from their therapy. The FDA has officially approved a label expansion for…